Exelixis (EXEL 1.92%) has been a solid stock to own over the past five years, with its shares climbing 101%, slightly beating ...
Swedish study of 600,000 patients between 17 and 60 years old suggests there is no safe age to get heavier ...
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who ...
Differentiated ²¹²Pb radiopharmaceutical platform designed to optimize tumor killing, safety, patient convenience and supply scalabilityThree clinical-stage oncology programs advancing across ...
New research presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that ...
Brain tumor symptoms a Mayo Clinic doctor monitors in her own body include headaches, fatigue, nausea or vomiting and ...
Levine encouraged Moore to go to rehab at the Betty Ford Center. She remained sober for the rest of her life and spoke ...
GLP-1 drugs like Ozempic and Wegovy offer surprising benefits beyond weight loss, but also carry unexpected risks.
Who they affect: Meningiomas are more common in older adults, especially women, with studies showing a 2.7% prevalence among 70-year-old women. When to act: Small, slow-growing tumors may only require ...
Detailed price information for Perspective Therapeutics Inc (CATX-A) from The Globe and Mail including charting and trades.
Global analysis presented at the European Congress on Obesity in Istanbul found rising obesity rates in high-income countries ...
The warning comes after an analysis of over 600,000 men and women who were weighed repeatedly over four decades found there ...